Federal award (BPA CALL, fiscal year 2022)
Recipient: BRILLIENT CORPORATION
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2020-05-05 to 2022-05-06
Current total value of award: $431889.44
Description: SERVICES FOR "EXPOSURE-BASED PARADIGM TO DEVELOP LONG ACTING CONTRACEPTIVES"